-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ITtlFmpsiizcTMIVzWLj/T8Mwmsupevr/BvgWJ5AF+WgC/hFcr6qVJsTbtefHBTk vJuaqTjEINIkVAOUmzuhXQ== 0001170918-05-000977.txt : 20051227 0001170918-05-000977.hdr.sgml : 20051226 20051227143349 ACCESSION NUMBER: 0001170918-05-000977 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20051220 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Changes in Registrant.s Certifying Accountant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20051227 DATE AS OF CHANGE: 20051227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALPHA INNOTECH CORP CENTRAL INDEX KEY: 0000830736 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 581729436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14257 FILM NUMBER: 051286810 BUSINESS ADDRESS: STREET 1: 2401 MERCED ST. CITY: SAN LEANDRO STATE: CA ZIP: 94577 BUSINESS PHONE: 5104839620 MAIL ADDRESS: STREET 1: 2401 MERCED ST. CITY: SAN LEANDRO STATE: CA ZIP: 94577 FORMER COMPANY: FORMER CONFORMED NAME: XTRANA INC DATE OF NAME CHANGE: 20010702 FORMER COMPANY: FORMER CONFORMED NAME: BIOPOOL INTERNATIONAL INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: CYTRX BIOPOOL LTD DATE OF NAME CHANGE: 19890716 8-K 1 fm8k-122005.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): DECEMBER 20, 2005 ALPHA INNOTECH CORP. (Exact name of registrant as specified in its charter) DELAWARE 1-14257 58-1729436 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 2401 MERCED STREET, SAN LEANDRO, CALIFORNIA 94577 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (510) 483-9620 N/A - -------------------------------------------------------------------------------- (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (SEE General Instruction A.2. below): |_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |_| Pre-commencement communications pursuant to Rule 13e-4(c)) under the Exchange Act (17 CFR 240.13e-4c)) ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT. On December 20, 2005, the Board of Directors of Alpha Innotech Corp. ("Alpha Innotech" or the "Company") approved a new compensation program for the Chairman of the Board of Directors of the Company, Bill Snider. Under the new compensation program, Mr. Snider shall be entitled to receive cash compensation for his service as Chairman of the Board of Directors equal to $8,333.33 per month for the period beginning January 1, 2006 and ending June 30, 2006, with potential additional cash payment upon the Company's achievement of certain performance milestones. Additionally, Mr. Snider was granted an option to purchase 300,000 shares of Common Stock, such option to vest with respect to 200,000 shares on June 30, 2006 and with respect to additional 100,000 on December 31, 2006, subject to the Company's achievement of certain performance milestones. A copy of the option agreement is filed as Exhibit 10.1 to this Form 8-K. ITEM 4.01 CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT. (a) On December 22, 2005, we ended the engagement of Hein & Associates LLP as our independent registered public accounting firm. The decision was approved by our Audit Committee and our Board of Directors. The report of Hein & Associates LLP on the Xtrana, Inc. financial statements for the fiscal year ended December 31, 2004 did not contain an adverse opinion or disclaimer of opinion. However, the report was modified due to an uncertainty about the ability of Xtrana, Inc. to continue as a going concern. During the fiscal year ended December 31, 2004 and the subsequent interim period preceding the termination, there were no disagreements with Hein & Associates LLP on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Hein & Associates LLP would have caused Hein & Associates LLP to make reference to the subject matter of the disagreements in connection with its report on the financial statements for such years or subsequent interim periods. We requested that Hein & Associates LLP furnish us with a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the our statements in this Item 4.01(a). A copy of the letter furnished by Hein & Associates LLP in response to that request, dated December 27, 2005, is filed as Exhibit 16.1 to this Form 8-K. (b) On December 22, 2005, Rowbotham & Company LLP was engaged as our new independent registered public accounting firm. During the two most recent fiscal years and the interim period preceding the engagement of Rowbotham & Company LLP, we have not consulted with Rowbotham & Company LLP regarding either: (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on our financial statements; or (ii) any matter that was either the subject of a disagreement or event identified in paragraph (a)(1)(iv) of Item 304 of Regulation S-B. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. (d) EXHIBITS. See the Exhibit Index following the signature page of this Current Report on Form 8-K for a list of the exhibits filed herewith. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ALPHA INNOTECH CORP. Date: December 27, 2005 By: /S/ HASEEB CHAUDHRY ---------------------------------------- Haseeb Chaudhry Chief Executive Officer 3 EXHIBIT INDEX EXHIBIT NUMBER DESCRIPTION - ------- ----------- 10.1 Option Agreement with Mr. Snider 16.1 Letter furnished by Hein & Associates LLP dated December 27, 2005 4 EX-10 2 ex10-1a.txt EX-10.1 EXHIBIT 10.1 ALPHA INNOTECH CORP. NOTICE OF STOCK OPTION GRANT William Snider 1901 Research Boulevard, Suite 350 Rockville, Maryland 20850 You have been granted an option to purchase Common Stock of Alpha Innotech Corp., (the "COMPANY") as follows: Board Approval Date: December 20, 2005 Date of Grant (Later of Board Approval Date or Commencement of Employment/Consulting): December 20, 2005 Exercise Price Per Share: $1.46 Total Number of Shares Granted: 300,000 Total Exercise Price: $438,000 Type of Option: 300,000 Shares Nonstatutory Stock Option Expiration Date: December 20, 2015 Vesting Commencement Date: June 30, 2006 Vesting/Exercise Schedule: So long as your directorship, employment or consulting relationship with the Company continues, the Shares underlying this Option shall vest and become exercisable in accordance with the following schedule: 200,000 of the Shares subject to the Option shall vest and become exercisable on June 30, 2006 and 100,000 of the total number of Shares subject to the Option shall vest and become exercisable on December 31, 2006, subject to completion of certain milestones, set forth on Exhibit B hereto. Termination Period: Option may be exercised for 60 days after termination of directorship, employment or consulting relationship except as set out in Section 5 of the Stock Option Agreement (but in no event later than the Expiration Date). Optionee is responsible for keeping track of these exercise periods following termination for any reason of his or her service relationship with the Company. The Company will not provide further notice of such periods. Transferability: This Option may not be transferred. By your signature and the signature of the Company's representative below, you and the Company agree that this option is granted under and governed by the terms and conditions of the Stock Option Agreement, which is attached and made a part of this document. In addition, you agree and acknowledge that your rights to any Shares underlying the Option will be earned only as you provide services to the Company over time, that the grant of the Option is not as consideration for services you rendered to the Company prior to your Vesting Commencement Date, and that nothing in this Notice or the attached documents confers upon you any right to continue your employment or consulting relationship with the Company for any period of time, nor does it interfere in any way with your right or the Company's right to terminate that relationship at any time, for any reason, with or without cause. ALPHA INNOTECH CORP. By: - -------------------------------------- ------------------------------ William Snider Name: ------------------------------ Title: ------------------------------ - -------------------------------------- Print Name -2- ALPHA INNOTECH CORP. STOCK OPTION AGREEMENT 1. GRANT OF OPTION. Alpha Innotech Corp., a Delaware corporation (the "COMPANY"), hereby grants to William Snider ("OPTIONEE"), an option (the "OPTION") to purchase the total number of shares of Common Stock (the "SHARES") set forth in the Notice of Stock Option Grant (the "NOTICE"), at the exercise price per Share set forth in the Notice (the "EXERCISE PRICE"). This Stock Option Agreement shall be deemed executed by the Company and Optionee upon execution by such parties of the Notice. 2. DESIGNATION OF OPTION. This Option is intended to be a Nonstatutory Stock Option. 3. EXERCISE OF OPTION. This Option shall be exercisable during its term in accordance with the Vesting/Exercise Schedule set out in the Notice as follows: (a) RIGHT TO EXERCISE. (i) This Option may not be exercised for a fraction of a share. (ii) In the event of Optionee's death, disability or other termination of employment, the exercisability of the Option is governed by Section 5 below, subject to the limitations contained in this Section 3. (iii) In no event may this Option be exercised after the Expiration Date of the Option as set forth in the Notice. (b) METHOD OF EXERCISE. (i) This Option shall be exercisable by delivering to the Company a written notice of exercise (in the form attached as EXHIBIT A or in any other form of notice approved by the Board of Directors) which shall state Optionee's election to exercise the Option, the number of Shares in respect of which the Option is being exercised, and such other representations and agreements as to the holder's investment intent with respect to such Shares as may be required by the Company. Such written notice shall be signed by Optionee and shall be delivered to the Company by such means as are determined by the Board of Directors in its discretion to constitute adequate delivery. The written notice shall be accompanied by payment of the Exercise Price. This Option shall be deemed to be exercised upon receipt by the Company of such written notice accompanied by the Exercise Price. (ii) As a condition to the exercise of this Option, Optionee agrees to make adequate provision for federal, state or other tax withholding obligations, if any, which arise upon the vesting or exercise of the Option, or disposition of Shares, whether by withholding, direct payment to the Company, or otherwise. -3- (iii) The Company is not obligated, and will have no liability for failure, to issue or deliver any Shares upon exercise of the Option unless such issuance or delivery would comply with the applicable laws, with such compliance determined by the Company in consultation with its legal counsel. This Option may not be exercised if the issuance of such Shares upon such exercise or the method of payment of consideration for such shares would constitute a violation of any applicable federal or state securities or other law or regulation, including any rule under Part 221 of Title 12 of the Code of Federal Regulations as promulgated by the Federal Reserve Board. As a condition to the exercise of this Option, the Company may require Optionee to make any representation and warranty to the Company as may be required by the applicable laws. Assuming such compliance, for income tax purposes the Shares shall be considered transferred to Optionee on the date on which the Option is exercised with respect to such Shares. 4. METHOD OF PAYMENT. Payment of the Exercise Price shall be by any of the following, or a combination of the following, at the election of Optionee: (a) cash or check; or (b) delivery of a properly executed exercise notice together with irrevocable instructions to a broker approved by the Company to deliver promptly to the Company the amount of sale or loan proceeds required to pay the exercise price. 5. TERMINATION OF RELATIONSHIP. Following the date of termination of Optionee's continuous employment, consulting or directorship for any reason (the "TERMINATION DATE"), Optionee may exercise the Option only as set forth in the Notice and this Section 5. To the extent that Optionee is not entitled to exercise this Option as of the Termination Date, or if Optionee does not exercise this Option within the Termination Period set forth in the Notice or the termination periods set forth below, the Option shall terminate in its entirety. In no event, may any Option be exercised after the Expiration Date of the Option as set forth in the Notice. (a) TERMINATION. In the event of termination of Optionee's continuous employment, consulting or directorship other than as a result of Optionee's disability or death, Optionee may, to the extent the Shares are vested and the Optionee is otherwise so entitled at the date of such termination (the "TERMINATION DATE"), exercise this Option during the Termination Period set forth in the Notice. (b) OTHER TERMINATIONS. In connection with any termination other than a termination covered by Section 5(a), Optionee may exercise the Option only as described below: (i) TERMINATION UPON DISABILITY OF OPTIONEE. In the event of termination of Optionee's continuous employment, consulting or directorship as a result of Optionee's disability, Optionee may, but only within six months from the Termination Date, exercise this Option to the extent the Shares are vested and the Optionee was entitled to exercise it as of such Termination Date. -4- (ii) DEATH OF OPTIONEE. In the event of the death of Optionee (a) during the term of this Option and while an Employee or Consultant of the Company and having been in continuous employment, consulting or directorship since the date of grant of the Option, or (b) within thirty (30) days after Optionee's Termination Date, the Option may be exercised at any time within six months following the date of death by Optionee's estate or by a person who acquired the right to exercise the Option by bequest or inheritance, but only to the extent the Option Shares are vested and the Optionee was entitled to exercise the Option as of the Termination Date. 6. NON-TRANSFERABILITY OF OPTION. This Option may not be transferred in any manner otherwise than by will or by the laws of descent or distribution and may be exercised during the lifetime of Optionee only by him or her. The terms of this Option shall be binding upon the executors, administrators, heirs, successors and assigns of Optionee. 7. TAX CONSEQUENCES. The Company has not provided any tax advice with respect to this Option or the disposition of the Shares. Optionee should obtain advice from an appropriate independent professional adviser with respect to the taxation implications of the grant, exercise, assignment, release, cancellation or any other disposal of this Option and on any subsequent sale or disposition of the Shares. 8. ADJUSTMENTS UPON CHANGES IN CAPITALIZATION; CORPORATE TRANSACTIONS. (a) ADJUSTMENT. Subject to any required action by the stockholders of the Company, the number of Shares shall be proportionately adjusted for any increase or decrease in the number of issued shares of Common Stock resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of the Common Stock, or any other increase or decrease in the number of issued shares of Common Stock effected without receipt of consideration by the Company; PROVIDED, HOWEVER, that conversion of any convertible securities of the Company shall not be deemed to have been "effected without receipt of consideration." Such adjustment shall be made by the Board, whose determination in that respect shall be final, binding and conclusive. Except as expressly provided herein, no issuance by the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares of Common Stock subject to this Option. (b) CORPORATE TRANSACTIONS. In the event of (i) a dissolution or liquidation of the Company, (ii) a sale of all or substantially all of the Company's assets, (iii) a merger or consolidation in which the Company is not the surviving corporation, or (iv) any other capital reorganization in which more than fifty percent (50%) of the shares of the Company entitled to vote are exchanged, the Company shall give to the Optionee, at the time of adoption of the plan for liquidation, dissolution, sale, merger, consolidation or reorganization, either a reasonable time thereafter within which to exercise the Option, including Shares as to which the Option would not be otherwise exercisable, prior to the effectiveness of such liquidation, dissolution, sale, merger, consolidation or reorganization, at the end of which time the Option shall terminate, or the right to exercise the Option, including Shares as to which the Option would not be otherwise exercisable (or receive a substitute option with comparable terms), as to an equivalent number of -5- shares of stock of the corporation succeeding the Company or acquiring its business by reason of such liquidation, dissolution, sale, merger, consolidation or reorganization. 9. EFFECT OF AGREEMENT. Optionee hereby accepts this Option and agrees to be bound by its contractual terms. Optionee hereby agrees to accept as binding, conclusive and final all decisions and interpretations of the Board of Directors regarding any questions relating to the Option. The Option constitutes the entire agreement between Optionee and the Company on the subject matter hereof and supersedes all proposals, written or oral, and all other communications between the parties relating to such subject matter. -6- EXHIBIT A NOTICE OF EXERCISE To: Alpha Innotech Corp. Attn: Stock Option Administrator Subject: NOTICE OF INTENTION TO EXERCISE STOCK OPTION This is official notice that the undersigned ("OPTIONEE") intends to exercise Optionee's option to purchase __________ shares of Alpha Innotech Corp. Common Stock, under and pursuant to the Stock Option Agreement dated December __, 2005, as follows: Grant Number: ---------------------------------------- Date of Purchase: ---------------------------------------- Number of Shares: ---------------------------------------- Purchase Price: ---------------------------------------- Method of Payment of Purchase Price: ---------------------------------------- Social Security No.: ------------------------------------------------ The shares should be issued as follows: Name: ---------------------------------------- Address: ---------------------------------------- ---------------------------------------- ---------------------------------------- Signed: ---------------------------------------- Date: ---------------------------------------- EX-16 3 ex16-1.txt EX-16.1 EXHIBIT 16.1 December 27, 2005 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 RE: Alpha Innotech Corp. (formerly Xtrana, Inc.) File No. 001-14257 Dear Sirs: We have read Item 4.01(a) of Alpha Innotech Corp. Form 8-K, dated December 27, 2005, and are in agreement with the statements contained in Item 4.01(a) therein as they relate to us. Very truly yours, /s/ HEIN & ASSOCIATES LLP - ------------------------- Hein & Associates LLP -----END PRIVACY-ENHANCED MESSAGE-----